Evidence map›Paper›PMID 38336881›Full record

ArticleNature microbiology2024

Synthesis of lipid-linked precursors of the bacterial cell wall is governed by a feedback control mechanism in Pseudomonas aeruginosa.

Lindsey S Marmont, Anna K Orta, Becca W A Baileeves, David Sychantha, Ana Fernández-Galliano, Yancheng E Li, Neil G Greene, Robin A Corey, Phillip J Stansfeld, William M Clemons and 1 more

Abstract read
In one paragraph

Article in Nature microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Lindsey S MarmontDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Anna K OrtaDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0002-8526-0383
Becca W A BaileevesSchool of Life Sciences and Department of Chemistry, University of Warwick, Coventry, UK.ORCID http://orcid.org/0009-0000-6699-0367
David SychanthaMichael DeGroote Institute for Infectious Disease Research, David Braley Centre for Antibiotic Discovery, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.ORCID http://orcid.org/0000-0002-3497-1599
Ana Fernández-GallianoMichael DeGroote Institute for Infectious Disease Research, David Braley Centre for Antibiotic Discovery, Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.ORCID http://orcid.org/0009-0004-9368-1358
Yancheng E LiDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0002-7110-2448
Neil G GreeneDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Robin A CoreySchool of Physiology, Pharmacology, and Neuroscience, University of Bristol, Bristol, UK.
Phillip J StansfeldSchool of Life Sciences and Department of Chemistry, University of Warwick, Coventry, UK.ORCID http://orcid.org/0000-0001-8800-7669
William M ClemonsDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Thomas G BernhardtDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. thomas_bernhardt@hms.harvard.edu.ORCID http://orcid.org/0000-0003-3566-7756

Funding

Peptidoglycan Biogenesis in Escherichia ColiR01AI083365 · NIAID · HARVARD MEDICAL SCHOOL · PI Thomas G Bernhardt · 2010 to 2026
$8.3M
Mechanistic details of key integral-membrane enzymes for antimicrobial discoveryR01GM114611 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI William M. Clemons, Michio Kurosu · 2016 to 2026
$4.2M
Medical Research Council MR/S009213/1NIAID NIH HHS R01 AI083365NIGMS NIH HHS R01 GM114611Wellcome Trust
6 · The paper itself

Abstract

Many bacterial surface glycans such as the peptidoglycan (PG) cell wall are built from monomeric units linked to a polyprenyl lipid carrier. How this limiting carrier is distributed among competing pathways has remained unclear. Here we describe the isolation of hyperactive variants of Pseudomonas aeruginosa MraY, the enzyme that forms the first lipid-linked PG precursor. These variants result in the elevated production of the final PG precursor lipid II in cells and are hyperactive in vitro. The activated MraY variants have substitutions that map to a cavity on the extracellular side of the dimer interface, far from the active site. Our structural and molecular dynamics results suggest that this cavity is a binding site for externalized lipid II. Overall, our results support a model in which excess externalized lipid II allosterically inhibits MraY, providing a feedback mechanism that prevents the sequestration of lipid carrier in the PG biogenesis pathway.

Indexed as

BacteriaPseudomonas aeruginosaCell WallFeedbackLipidsLipids

Identifiers

PMID38336881
PMCPMC10914600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.